Global Oral Solid Dosage Formulation Development Service Market Research Report 2025

Publication ID:

PB504251160

Publication Date:

April 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Oral Solid Dosage Formulation Development Service was valued at US$ 226 million in the year 2024 and is projected to reach a revised size of US$ 285 million by 2031, growing at a CAGR of 3.4% during the forecast period.
North American market for Oral Solid Dosage Formulation Development Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Oral Solid Dosage Formulation Development Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Oral Solid Dosage Formulation Development Service in SMEs is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Oral Solid Dosage Formulation Development Service include Pfizer, Evonik Industries, Societal, Aurigene Pharmaceutical Services, Thermo Fisher Scientific, Skyepharma Production, Recipeharm, UPM Pharmaceuticals, Crystal Pharmatech, Almac Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oral Solid Dosage Formulation Development Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Solid Dosage Formulation Development Service.
The Oral Solid Dosage Formulation Development Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Solid Dosage Formulation Development Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Solid Dosage Formulation Development Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Evonik Industries
Societal
Aurigene Pharmaceutical Services
Thermo Fisher Scientific
Skyepharma Production
Recipeharm
UPM Pharmaceuticals
Crystal Pharmatech
Almac Group
Alcami
Lonza
Catalent
Ascendia
Segment by Type
Tablet
Capsule
Powder
Segment by Application
SMEs
Large Enterprises
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Solid Dosage Formulation Development Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Solid Dosage Formulation Development Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Powder
1.3 Market by Application
1.3.1 Global Oral Solid Dosage Formulation Development Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 SMEs
1.3.3 Large Enterprises
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Solid Dosage Formulation Development Service Market Perspective (2020-2031)
2.2 Global Oral Solid Dosage Formulation Development Service Growth Trends by Region
2.2.1 Global Oral Solid Dosage Formulation Development Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oral Solid Dosage Formulation Development Service Historic Market Size by Region (2020-2025)
2.2.3 Oral Solid Dosage Formulation Development Service Forecasted Market Size by Region (2026-2031)
2.3 Oral Solid Dosage Formulation Development Service Market Dynamics
2.3.1 Oral Solid Dosage Formulation Development Service Industry Trends
2.3.2 Oral Solid Dosage Formulation Development Service Market Drivers
2.3.3 Oral Solid Dosage Formulation Development Service Market Challenges
2.3.4 Oral Solid Dosage Formulation Development Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Solid Dosage Formulation Development Service Players by Revenue
3.1.1 Global Top Oral Solid Dosage Formulation Development Service Players by Revenue (2020-2025)
3.1.2 Global Oral Solid Dosage Formulation Development Service Revenue Market Share by Players (2020-2025)
3.2 Global Oral Solid Dosage Formulation Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oral Solid Dosage Formulation Development Service Revenue
3.4 Global Oral Solid Dosage Formulation Development Service Market Concentration Ratio
3.4.1 Global Oral Solid Dosage Formulation Development Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Solid Dosage Formulation Development Service Revenue in 2024
3.5 Global Key Players of Oral Solid Dosage Formulation Development Service Head office and Area Served
3.6 Global Key Players of Oral Solid Dosage Formulation Development Service, Product and Application
3.7 Global Key Players of Oral Solid Dosage Formulation Development Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Solid Dosage Formulation Development Service Breakdown Data by Type
4.1 Global Oral Solid Dosage Formulation Development Service Historic Market Size by Type (2020-2025)
4.2 Global Oral Solid Dosage Formulation Development Service Forecasted Market Size by Type (2026-2031)
5 Oral Solid Dosage Formulation Development Service Breakdown Data by Application
5.1 Global Oral Solid Dosage Formulation Development Service Historic Market Size by Application (2020-2025)
5.2 Global Oral Solid Dosage Formulation Development Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oral Solid Dosage Formulation Development Service Market Size (2020-2031)
6.2 North America Oral Solid Dosage Formulation Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oral Solid Dosage Formulation Development Service Market Size by Country (2020-2025)
6.4 North America Oral Solid Dosage Formulation Development Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Solid Dosage Formulation Development Service Market Size (2020-2031)
7.2 Europe Oral Solid Dosage Formulation Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oral Solid Dosage Formulation Development Service Market Size by Country (2020-2025)
7.4 Europe Oral Solid Dosage Formulation Development Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Solid Dosage Formulation Development Service Market Size (2020-2031)
8.2 Asia-Pacific Oral Solid Dosage Formulation Development Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oral Solid Dosage Formulation Development Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Oral Solid Dosage Formulation Development Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Solid Dosage Formulation Development Service Market Size (2020-2031)
9.2 Latin America Oral Solid Dosage Formulation Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oral Solid Dosage Formulation Development Service Market Size by Country (2020-2025)
9.4 Latin America Oral Solid Dosage Formulation Development Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Solid Dosage Formulation Development Service Market Size (2020-2031)
10.2 Middle East & Africa Oral Solid Dosage Formulation Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oral Solid Dosage Formulation Development Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Oral Solid Dosage Formulation Development Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Oral Solid Dosage Formulation Development Service Introduction
11.1.4 Pfizer Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Evonik Industries
11.2.1 Evonik Industries Company Details
11.2.2 Evonik Industries Business Overview
11.2.3 Evonik Industries Oral Solid Dosage Formulation Development Service Introduction
11.2.4 Evonik Industries Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)
11.2.5 Evonik Industries Recent Development
11.3 Societal
11.3.1 Societal Company Details
11.3.2 Societal Business Overview
11.3.3 Societal Oral Solid Dosage Formulation Development Service Introduction
11.3.4 Societal Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)
11.3.5 Societal Recent Development
11.4 Aurigene Pharmaceutical Services
11.4.1 Aurigene Pharmaceutical Services Company Details
11.4.2 Aurigene Pharmaceutical Services Business Overview
11.4.3 Aurigene Pharmaceutical Services Oral Solid Dosage Formulation Development Service Introduction
11.4.4 Aurigene Pharmaceutical Services Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)
11.4.5 Aurigene Pharmaceutical Services Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Oral Solid Dosage Formulation Development Service Introduction
11.5.4 Thermo Fisher Scientific Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Skyepharma Production
11.6.1 Skyepharma Production Company Details
11.6.2 Skyepharma Production Business Overview
11.6.3 Skyepharma Production Oral Solid Dosage Formulation Development Service Introduction
11.6.4 Skyepharma Production Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)
11.6.5 Skyepharma Production Recent Development
11.7 Recipeharm
11.7.1 Recipeharm Company Details
11.7.2 Recipeharm Business Overview
11.7.3 Recipeharm Oral Solid Dosage Formulation Development Service Introduction
11.7.4 Recipeharm Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)
11.7.5 Recipeharm Recent Development
11.8 UPM Pharmaceuticals
11.8.1 UPM Pharmaceuticals Company Details
11.8.2 UPM Pharmaceuticals Business Overview
11.8.3 UPM Pharmaceuticals Oral Solid Dosage Formulation Development Service Introduction
11.8.4 UPM Pharmaceuticals Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)
11.8.5 UPM Pharmaceuticals Recent Development
11.9 Crystal Pharmatech
11.9.1 Crystal Pharmatech Company Details
11.9.2 Crystal Pharmatech Business Overview
11.9.3 Crystal Pharmatech Oral Solid Dosage Formulation Development Service Introduction
11.9.4 Crystal Pharmatech Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)
11.9.5 Crystal Pharmatech Recent Development
11.10 Almac Group
11.10.1 Almac Group Company Details
11.10.2 Almac Group Business Overview
11.10.3 Almac Group Oral Solid Dosage Formulation Development Service Introduction
11.10.4 Almac Group Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)
11.10.5 Almac Group Recent Development
11.11 Alcami
11.11.1 Alcami Company Details
11.11.2 Alcami Business Overview
11.11.3 Alcami Oral Solid Dosage Formulation Development Service Introduction
11.11.4 Alcami Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)
11.11.5 Alcami Recent Development
11.12 Lonza
11.12.1 Lonza Company Details
11.12.2 Lonza Business Overview
11.12.3 Lonza Oral Solid Dosage Formulation Development Service Introduction
11.12.4 Lonza Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)
11.12.5 Lonza Recent Development
11.13 Catalent
11.13.1 Catalent Company Details
11.13.2 Catalent Business Overview
11.13.3 Catalent Oral Solid Dosage Formulation Development Service Introduction
11.13.4 Catalent Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)
11.13.5 Catalent Recent Development
11.14 Ascendia
11.14.1 Ascendia Company Details
11.14.2 Ascendia Business Overview
11.14.3 Ascendia Oral Solid Dosage Formulation Development Service Introduction
11.14.4 Ascendia Revenue in Oral Solid Dosage Formulation Development Service Business (2020-2025)
11.14.5 Ascendia Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Pfizer
Evonik Industries
Societal
Aurigene Pharmaceutical Services
Thermo Fisher Scientific
Skyepharma Production
Recipeharm
UPM Pharmaceuticals
Crystal Pharmatech
Almac Group
Alcami
Lonza
Catalent
Ascendia

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂